Subsequent surveys have determined the relevance of both BChE and AchE in the pathophysiology of Alzheimer’s disease and have demonstrated the therapeutic benefit of the inhibition of both BchE and AchE. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.